Injection for Chronic Back Pain
Published: 2011-05-19
Author: University of Manchester
Peer-Reviewed: N/A
Related Papers: Latest Items - Full List
On This Page: Summary - Main Article
Synopsis: Biomaterial implant may finally bring treatment in the form of a jab for chronic back pain. Implant jab could solve the misery of back pain - University of Manchester scientists have developed a biomaterial implant which could finally bring treatment, in the form of a jab, for chronic back pain.
Main Digest
Implant jab could solve the misery of back pain - University of Manchester scientists have developed a biomaterial implant which could finally bring treatment, in the form of a jab, for chronic back pain.advertisement
Chronic lower back pain is a major problem for society - behind only headaches as the most common neurological ailment - and is frequently caused by degeneration of the intervertebral disc.
Researchers have worked for many years to find a way of repairing the wear and tear on the lower back.
Now, in results published in the journal Soft Matter, they have discovered how to permanently replace the workings of the invertebrate disc.
It is estimated that back pain affects 80% of people at some point in their lives. In the United States it is the most common cause of job-related disability, a leading contributor to people missing work. The University of Manchester cross-faculty team have been working with microgel particles, which are swell-able nanoscopic polymer particles, for a number of years.
Previously, they have demonstrated that an injectable fluid of these particles could transform into a gel that restored the mechanical properties of damaged model intervertebral discs.
Lead researcher Dr Brian Saunders, of the School of Materials, and his team have now succeeded in linking the microgel particles together to form injectable durable, elastic gels capable of sustaining large permanent changes in shape without breaking.
These improved injectable gels have much better mechanical properties than the first generation and should now display the necessary long-term durability required for an implanted device.
In this study the researchers - who include PhD student Amir Milani and Dr Ruixue Liu - have achieved an important milestone for producing injectable gels for minimally-invasive repair of IVD degeneration.
Dr Saunders said: ""Our team has made a breakthrough through innovative materials design that brings the prospect of an injectable gel for treating degeneration of the intervertebral disc a step closer.
Professor Tony Freemont, Head of Research in the School of Biomedicine, and co-author on the paper, added: "Degeneration of the intervertebral disc results in chronic back pain which costs the country billions of pounds per annum and causes untold misery for sufferers and their families.
"We have been working for 25 years to identify methods for treating degeneration of the intervertebral disc."
This work has been funded by the EPSRC and was recently awarded Proof-of-Principle (PoP) funding by The University of Manchester Intellectual Property Limited (UMIP).
Share This Information To:
𝕏.com Facebook Reddit
Discover Related Topics:
advertisement
Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.
Permalink: <a href="https://www.disabled-world.com/disability/types/spinal/backpain/back-pain-injection.php">Injection for Chronic Back Pain</a>
Cite This Page (APA): University of Manchester. (2011, May 19). Injection for Chronic Back Pain. Disabled World. Retrieved September 22, 2023 from www.disabled-world.com/disability/types/spinal/backpain/back-pain-injection.php
Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.